Skip to main content
رجوع
Watch Compare

Connect Biopharma Holdings Ltd

جودة البيانات: 100%
CNTB
Nasdaq Manufacturing Chemicals
KWD 2.80
▲ KWD 0.17 (6.46%)
القيمة السوقية: 158.26 M
السعر
KWD 2.80
القيمة السوقية
158.26 M
نطاق اليوم
KWD 2.58 — KWD 2.87
نطاق 52 أسبوعًا
KWD 0.60 — KWD 3.82
حجم التداول
245,127
فتح KWD 2.61
متوسط 50 يوم / 200 يوم
KWD 2.71
3.44% above
متوسط 50 يوم / 200 يوم
KWD 2.13
31.68% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -51.64 M
Capital intensive — 678.13% of revenue goes to capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-99.75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-87.57%
أقل من متوسط القطاع (-53.47%)
ROIC-71.73%
Net Margin-86687.50%
Op. Margin-90740.63%

الأمان

Debt / Equity
N/A
Current Ratio5.48
Interest CoverageN/A

التقييم

PE (TTM)
-2.85
أقل من متوسط القطاع (-1.47)
P/B Ratio2.86
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -2.9 -1.5
P/B 2.9 1.6
ROE % -87.6 -53.5
Net Margin % -86687.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -99.75% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 64,000.0 Net Income (TTM) -55.48 M
ROE -87.57% ROA -73.93%
Gross Margin N/A Operating Margin -90740.63%
Net Margin -86687.50% Free Cash Flow (TTM) -51.64 M
ROIC -71.73% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.48
Interest Coverage N/A Asset Turnover 0.00
Working Capital 51.17 M Tangible Book Value 55.32 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.85 Forward P/E N/A
P/B Ratio 2.86 P/S Ratio 2472.81
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.63%
Market Cap 158.26 M Enterprise Value 120.41 M
Per Share
EPS (Diluted TTM) -1.00 Revenue / Share 0.00
FCF / Share -0.91 OCF / Share -0.91
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 678.13% FCF Conversion 93.08%
SBC-Adj. FCF -55.37 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 64,000.0 26.03 M
Net Income -55.48 M -15.63 M
EPS (Diluted) -1.00 -0.28
Gross Profit — —
Operating Income -58.07 M -22.45 M
EBITDA — —
R&D Expenses 37.80 M 29.26 M
SG&A Expenses — —
D&A 704,000.0 660,000.0
Interest Expense — —
Income Tax 197,000.0 223,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 56.08 M 101.28 M
Total Liabilities 14.10 M 9.12 M
Shareholders' Equity 41.98 M 92.17 M
Total Debt — —
Cash & Equivalents 38.35 M 78.23 M
Current Assets 50.93 M 96.96 M
Current Liabilities 13.61 M 8.46 M